TheraSure-CNI Monitor
Commercial- Indications
- Cancer therapy monitoring
Company intelligence / Profile preview
Chronix Biomedical
San Jose, California, United Statesinvestors.oncocyte.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Chronix Biomedical developed proprietary blood-based molecular diagnostic tests using copy number instability analysis of circulating cell-free DNA. Their technology enabled non-invasive screening and monitoring of cancers such as breast and prostate cancer, as well as transplant rejection. The company’s CNI platform was licensed and later acquired by Oncocyte in 2021.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Diagnostic test (liquid biopsy)Molecular diagnostics
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Oncocyte (licensing/collaboration prior to acquisition)large EU-based lab group with exclusive license for Germany, Austria, Switzerland, Belgium
Beyond the preview
Go deeper on Chronix Biomedical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chronix Biomedical.